Sélection d’articles sur les phéochromocytomes et paragangliomes
Février 2017
– Targeting PI3K/mTOR signaling exerts potent antitumor activity in pheochromocytoma in vivo
Lee M et al. – Endocr Relat Cancer. 2017 Jan;24(1):1-15. Epub 2016 Nov 3.
– Successful response to pegylated interferon alpha in a patient with recurrent paraganglioma
Bahougne T et al – Endocr Relat Cancer. 2017 Feb;24(2):L7-L11. doi: 10.1530/ERC-16-0431. Epub 2016 Nov 28
– The MITF, p.E318K Variant, as a Risk Factor for Pheochromocytoma and Paraganglioma.
Castro-Vega LJ et al – J Clin Endocrinol Metab. 2016 Dec;101(12):4764-4768. Epub 2016 Sep 28.
– Rapid-sequence MRI for long-term surveillance for paraganglioma and phaeochromocytoma in patients with succinate dehydrogenase mutations
Daniel E et al. – Eur J Endocrinol. 2016 Dec;175(6):561-570. Epub 2016 Sep 15
– Recurrence or new tumors after complete resection of pheochromocytomas and paragangliomas: a systematic review and meta-analysis
Amar L et al. – Eur J Endocrinol. 2016 Oct;175(4):R135-45. doi: 10.1530/EJE-16-0189. Epub 2016 Apr 14.
– Germline mutations and genotype–phenotype correlation in Asian Indian patients with pheochromocytoma and paraganglioma.
Pandit R et al. – Eur J Endocrinol. 2016 Dec;175(7)311-323 X3
– Interest of systematic screening of pheochromocytoma in patients with neurofibromatosis type 1
Képénékian L et al. – Eur J Endocrinol. 2016 Oct;175(4):335-44. doi: 10.1530/EJE-16-0233. Epub 2016 Jul 22.
Janvier 2017
– Consensus Statement on next-generation-sequencing-based diagnostic testing of hereditary phaeochromocytomas and paragangliomas.
NGS in PPGL (NGSnPPGL) Study Group. Toledo RA et al. – Nat Rev Endocrinol. 2016 Nov 18. doi: 10.1038/nrendo.2016.185.
– A SDHC Founder Mutation Causes Paragangliomas (PGLs) in the French Canadians: New Insights on the SDHC-Related PGL
Bourdeau I et al – J Clin Endocrinol Metab. 2016 Dec;101(12):4710-4718. Epub 2016 Oct 4
– The MITF, p.E318K Variant, as a Risk Factor for Pheochromocytoma and Paraganglioma
Castro-Vega LJ et al. – J Clin Endocrinol Metab. 2016 Dec;101(12):4764-4768. Epub 2016 Sep 28
– Novel insights into the polycythemia–paraganglioma–somatostatinoma syndrome
Därr R et al. – Endocr Relat Cancer. 2016 Dec;23(12):899-908. Epub 2016 Sep 27
– Endocrine tumors associated with the vagus nerve
Varoquaux A et al. – Endocr Relat Cancer. 2016 Sep;23(9):R371-9. doi: 10.1530/ERC-16-0241. Epub 2016 Jul 12
Juillet 2016
– European Society of Endocrinology Clinical Practice Guideline for long-term follow-up of patients operated on for a phaeochromocytoma or a paraganglioma
Plouin PF et al. Eur J Endocrinol 2016 May;174(5):G1-G10. doi: 10.1530/EJE-16-0033
Mars 2016
– Epigenetic Mutation of the Succinate Dehydrogenase C Promoter in a Patient With Two Paragangliomas
Richter S et al. – J Clin Endocrinol Metab. 2016 Feb;101(2):359-63. doi: 10.1210/jc.2015-3856. Epub 2015 Dec 11.
– Complex MAX Rearrangement in a Family With Malignant Pheochromocytoma, Renal Oncocytoma, and Erythrocytosis.
Korpershoek E et al. – J Clin Endocrinol Metab. 2016 Feb;101(2):453-60. doi: 10.1210/jc.2015-2592. Epub 2015 Dec 15.
– Cushing Syndrome Due to ACTH-Secreting Pheochromocytoma, Aggravated by Glucocorticoid-Driven Positive-Feedback Loop.
Sakuma I et al. – J Clin Endocrinol Metab. 2016 Mar;101(3):841-6. doi: 10.1210/jc.2015-2855. Epub 2015 Dec 23.
– Pheo-Type: A Diagnostic Gene-expression Assay for the Classification of Pheochromocytoma and Paraganglioma.
Flynn A et al. – J Clin Endocrinol Metab. 2016 Mar;101(3):1034-43. doi: 10.1210/jc.2015-3889. Epub 2016 Jan 21.
– Longitudinal plasma metanephrines preceding pheochromocytoma diagnosis: a retrospective case–control serum repository study
S W Olson et al. – Eur J Endocrinol 174 (3) 289-295, doi: 10.1530/EJE-15-0651
Janvier 2016
– Pheochromocytoma Screening Initiation and Frequency in von Hippel-Lindau Syndrome Aufforth R.D. et al.
J Clin Endocrinol Metab. 2015 Dec;100 (12) :4498-504. doi: 10.1210/jc.2015-3045. Epub 2015 Oct 9.
– Management Of Endocrine Disease: Outcome of adrenal sparing surgery in heritable pheochromocytoma Castinetti F. et al.
Eur J Endocrinol. 2016 Jan;174 (1):R9-R18. doi: 10.1530/EJE-15-0549. Epub 2015 Aug 21. Review.